dQ&A is announcing upcoming data releases for our flagship products: Prescriber Perspectives (Europe) and Patient Voice (Europe).
Our T2 Insulin Insights is a semi-annual Research Service that explores the lived experience of people with type 2 diabetes who take insulin.
We are excited to announce dQ&A’s new syndicated qualitative research service, First Look Insights.
A national dQ&A survey of over 5,000 people with diabetes found wide variation in grocery store quality, with Aldi, Publix, Costco, H-E-B, and Hy-Vee rated highest.
This white paper outlines how psychographics reveal the drivers behind diabetes patient behaviors, helping predict actions and guide better decisions.
This survey shows COVID-19 booster rates are higher in U.S. adults with diabetes than the general population, but vary by race, income, and location.
Our survey finds major pharmacies often fail people with diabetes, with wide NPS score gaps; Sam’s Club, Publix, Costco, and U.S. Medical Supply rank highest.
We surveyed panel members about the FDA advisory on Provention Bio’s teplizumab to delay type 1 diabetes—discover their top concerns and expected impact.
This research reveals how stigma in diabetes—from HCPs and society—affects relationships, care decisions, mental health, and diabetes management.
